In March 2023, in St. Petersburg, FSUE Endopharm presented its product range and promising developments at the Forum “Healthy Society” organized by the project of Roscongress Foundation “Healthy Society” and the Ministry of Health of the Russian Federation, with the support of the Interparliamentary Assembly of the CIS Member States, the Government of the Leningrad region and the Ministry of Industry and Trade of the Russian Federation.
More than 600 people from 53 regions of Russia and 15 foreign countries took part in the Forum: Azerbaijan, Armenia, Great Britain, Germany, Kazakhstan, Kyrgyzstan, Moldova, Republic of Belarus, Republic of Cyprus, USA, Serbia, Tajikistan, Uzbekistan, France and Switzerland.
Based on the results of participation in the Forum, FSUE Endopharm concluded specific agreements with a number of potential counterparties in the field of export of manufactured products.
In order to discuss topical issues and prospects for the implementation of cooperation, in May, the Enterprise’s management made a working visit to the Republic of Serbia.
Representatives of FSUE Endopharm got acquainted with the production of immunobiological products at the Torlak Institute, visited the Institute of Oncology and Radiology in Belgrade and held working meetings with the leadership of the Ministry of Health of the Republic of Serbia and major pharmaceutical and distribution companies of the country.
Danica Gruicic, Minister of Health of the Republic of Serbia, during a meeting with the management of the Enterprise, noted that one of the critical issues of the healthcare system is to ensure the availability of a wide range of potent pain medicines for palliative patients.
In Russia, the issue of accessibility to pain therapy for needy patients, due to its social significance, is under special control of the Government of the Russian Federation, executive authorities and civil society.
FSUE Endopharm is a co-executor of the Action Plan (“road map”) “Improving the quality and accessibility of palliative care until 2024” approved by Golikova T.A., Deputy Prime Minister of the Russian Federation on July 28, 2020 No. 6551p-P12, pursuant to which the Enterprise annually expands nomenclature of domestic narcotic and psychotropic drugs.
Since 2016, FSUE Endopharm has introduced 13 new narcotic and psychotropic drugs, most of which are intended to provide medical care to palliative patients suffering from chronic pain and seizures. Currently, medical specialists in Russia have access to 29 domestic narcotic and psychotropic drugs in 10 dosage forms and 53 dosages, which makes it possible to fully provide pain relief for needy patients in all regions of the country in accordance with the recommendations of the Ministry of Health of Russia.
Based on the results of the meetings, the parties determined in details the implementation of cooperation in terms of developing the export of medicines in demand in the Republic of Serbia from the range of products manufactured by FSUE Endopharm.
Comment type is not specified in the component properties.